Patient Blood Management Market Analysis from 2022 to 2034 Containing Market Size, Share along with its CAGR, Forecast and Trends

Top Countries — Revenue

USD Million/Billion

Access the full forecast model.

Country-level data · Company profiles · Editable dataset · Analyst consultation included.

Patient Blood Management Market Analysis — Presence

Geographical Analysis

Click countries to explore
Loading map…

Regional and Country Analysis

Global Patient Blood Management Market Analysis 2026

Region / Country 2021 (A)2025 (A)2033 (P) CAGR
Global$ 12.13 Billionxxxxxxxx6.22%
North Americaxxxxxxxxxxxxxxxx
United Statesxxxxxxxxxxxxxxxx
Canadaxxxxxxxxxxxxxxxx
Mexicoxxxxxxxxxxxxxxxx
Europexxxxxxxxxxxxxxxx
United Kingdomxxxxxxxxxxxxxxxx
Francexxxxxxxxxxxxxxxx
Germanyxxxxxxxxxxxxxxxx
Italyxxxxxxxxxxxxxxxx
Russiaxxxxxxxxxxxxxxxx
Spainxxxxxxxxxxxxxxxx
Swedenxxxxxxxxxxxxxxxx
Denmarkxxxxxxxxxxxxxxxx
Switzerlandxxxxxxxxxxxxxxxx
Luxembourgxxxxxxxxxxxxxxxx
Rest of Europexxxxxxxxxxxxxxxx
Asia Pacificxxxxxxxxxxxxxxxx
Chinaxxxxxxxxxxxxxxxx
Japanxxxxxxxxxxxxxxxx
South Koreaxxxxxxxxxxxxxxxx
Indiaxxxxxxxxxxxxxxxx
Australiaxxxxxxxxxxxxxxxx
Singaporexxxxxxxxxxxxxxxx
Taiwanxxxxxxxxxxxxxxxx
South East Asiaxxxxxxxxxxxxxxxx
Rest of APACxxxxxxxxxxxxxxxx
South Americaxxxxxxxxxxxxxxxx
Brazilxxxxxxxxxxxxxxxx
Argentinaxxxxxxxxxxxxxxxx
Colombiaxxxxxxxxxxxxxxxx
Peruxxxxxxxxxxxxxxxx
Chilexxxxxxxxxxxxxxxx
Rest of South Americaxxxxxxxxxxxxxxxx
Middle Eastxxxxxxxxxxxxxxxx
Saudi Arabiaxxxxxxxxxxxxxxxx
Turkeyxxxxxxxxxxxxxxxx
UAExxxxxxxxxxxxxxxx
Egyptxxxxxxxxxxxxxxxx
Qatarxxxxxxxxxxxxxxxx
Rest of Middle Eastxxxxxxxxxxxxxxxx
Africaxxxxxxxxxxxxxxxx
East Africaxxxxxxxxxxxxxxxx
West Africaxxxxxxxxxxxxxxxx
North Africaxxxxxxxxxxxxxxxx
South Africaxxxxxxxxxxxxxxxx

A = Actual · E = Estimated · P = Projected · 🔒 Locked values require full access. Click headers to sort.

Unlock full regional dataset →

Segmentation Analysis

Patient Blood Management Market, By Product Type The product segment is expected to have the largest market share during the forecast period Instruments, ventilators, accessories, reagents & kits, and software are the several market segments in the patient blood management market. Due to a growth in trauma cases, the existence of numerous government organizations that control blood banks, and an increase in the need for blood following surgery, the instruments segment generated the most revenue. Due to the increased use of reagents and kits, growth in bloodstream infection, and rise in sepsis incidence, the reagents and kits segment is anticipated to experience the greatest CAGR throughout the projection period. Accessories Reagents and Kits Software Instruments

Accessories Patient Blood Management Market Analysis
XX
Accessories Market Size 2025
XX %
CAGR
Locked · Full data in paid report
Reagents and Kits Patient Blood Management Market Analysis
XX
Reagents and Kits Market Size 2025
XX %
CAGR
Locked · Full data in paid report
Software Patient Blood Management Market Analysis
XX
Software Market Size 2025
XX %
CAGR
Locked · Full data in paid report
Instruments Patient Blood Management Market Analysis
XX
Instruments Market Size 2025
XX %
CAGR
Locked · Full data in paid report

Market size by (Illustrative, 2025)
Share distribution (2025)

Disclaimer: The charts and graphs are for illustrative purposes only and do not represent actual market values. To access accurate quantitative data, please request a paid report or request free sample.

To learn more about market share and segmentation, request the free sample pages.

Competitor Analysis

Patient Blood Management Market News

26 April 2022

  • For the development of freeze-dried plasma Terumo Blood and cell technologies received a $10.6 million contract from the U.S. government

The contract is made with Medical Technology Enterprise Consortium (METEC) sponsored by the Defense Health Agency (DHA) and managed by the Naval Medical Research Center (NMRC) to drive healthcare advances for the battlefield.

Sep 2022

  • Grifols made an agreement with Canadian Blood Services to accelerate self-sufficiency in immunoglobulins for Canada

A long-time agreement has been signed between the Canadian blood service and Grifols, a major market player in plasma medicines which will lead to a significant increase in immunoglobulin medicines and vital plasma protein this will ensure domestic plasma self-sufficiency.

Click any bar or cell to request the full company profile
Top Companies (In no particular order)2022 (A)2023 (A)2024 (A)2025 (A)
SpecialityCare••• ••• ••• •••
Haemonetics Corporation••• ••• ••• •••
Baden Wuerttemberg Hessen••• ••• ••• •••
UPMC••• ••• ••• •••
B BRAUN••• ••• ••• •••
Instrumentation Laboratory••• ••• ••• •••

We Provide Regional Breakdown of this Companies and Company specific to any Country, Region, Product/ service as well. We cover market share analysis for publicly listed companies as well as privately held companies, subject to data availability.

Request company profile for validation →

Report Scope & Analysis

The patient blood management market was valued at USD 12.93 billion in 2022 and will reach USD 20.60 billion by 2030, registering a CAGR of 6% for the forecast period 2023-2030.

Introduction of Patient Blood Management

Patient blood management (PBM) is a procedure in which maximum use of a patient's own blood is obtained to avoid unnecessary blood transfusions during surgery. Patient blood management helps to reduce healthcare costs and ensures the availability of blood components to the patient. The rising recognition of the importance of donated blood from the many sectors of the healthcare system, placenta research, and life sciences for the development of the medical industry is a significant factor in boosting the growth of the Patient blood management Market.

Analyst Conclusion

Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.

The Patient Blood Management Market Analysis is witnessing significant growth in the near future.

In 2023, the Accessories segment accounted for a notable share of the Patient Blood Management Market Analysis.

Supriya Yadav
Supriya Yadav Verified Analyst
Research Analyst
LinkedIn Profile Book a free Consultation

Frequently Asked Questions

Patient Blood Management Market Analysis market size and growth rate is provided in the report covering 2021-2025 historical and 2025-2033 forecast data.
Major factors including drivers, restraints, opportunities and challenges are analyzed with detailed insights.
Top manufacturers SpecialityCare, Haemonetics Corporation, Baden Wuerttemberg Hessen, UPMC, B BRAUN, Instrumentation Laboratory and others are profiled in the report.
Segments include Product Type, Component and additional sub-segments.
Regional analysis covers all major markets. The report identifies the dominant region and provides country-level data.
Sample pages can be obtained on demand from the website. 24/7 chat support and direct call services are available.

★ Reviews

Rate this report

Patient Blood Management Market Analysis — Table of Contents

Disclaimer:
  • This is just a redacted sample pages of the actual deliverable report and only for representative purposes
  • Charts/Graphs/Numbers/data are only for Representative purposes and do not depict actual statistics.
  • The table of Contents differs according to the user License selection. Current Displayed TOC is for the Corporate User License Report Edition. TOC Customization options: Add or Remove section/s Or chapter/s from the report.
  • Specific Tables, Graphs, Sections, and Chapters can be ordered at a discounted price.
  • If applicable; On Request Volume Data will also be provided (at an Additional Cost).
Report Scope
Product TypeAccessories, Reagents and Kits, Software, Instruments
ComponentPlasma, Whole Blood
End-UserHospitals, Pathology Labs, Diagnostic Clinics, Blood Banks
List of CompetitorsSpecialityCare, Haemonetics Corporation, Baden Wuerttemberg Hessen, UPMC, B BRAUN, Instrumentation Laboratory

  • Chapter 1. Competitor Analysis (Subject to Data Availability (Private Players))

    • 1.1 Top Competitors Analysis
      • 1.1.1 Global Patient Blood Management Market Analysis by Key Players
      • 1.1.2 Segment Market Analysis by Key Players
      • 1.1.3 Top Players Ranking 2024
      • 1.1.4 New Product Launch Analysis
      • 1.1.5 Industry Mergers and Acquisition Analysis
    • 1.2 Company Profile (Data Subject to Availability) Sample Format
      • 1.2.1 SpecialityCare
        • 1.2.1.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
        • 1.2.1.2 Business Overview
        • 1.2.1.3 Financials (Subject to data availability)
        • 1.2.1.4 R&D Investment (Subject to data availability)
        • 1.2.1.5 Product Types Specification
        • 1.2.1.6 Business Strategy
        • 1.2.1.7 Recent Developments
        • 1.2.1.8 Management Change
        • 1.2.1.9 S.W.O.T Analysis
      • 1.2.2 Haemonetics Corporation
        • 1.2.2.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
        • 1.2.2.2 Business Overview
        • 1.2.2.3 Financials (Subject to data availability)
        • 1.2.2.4 R&D Investment (Subject to data availability)
        • 1.2.2.5 Product Types Specification
        • 1.2.2.6 Business Strategy
        • 1.2.2.7 Recent Developments
        • 1.2.2.8 Management Change
        • 1.2.2.9 S.W.O.T Analysis
      • 1.2.3 Baden Wuerttemberg Hessen
        • 1.2.3.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
        • 1.2.3.2 Business Overview
        • 1.2.3.3 Financials (Subject to data availability)
        • 1.2.3.4 R&D Investment (Subject to data availability)
        • 1.2.3.5 Product Types Specification
        • 1.2.3.6 Business Strategy
        • 1.2.3.7 Recent Developments
        • 1.2.3.8 Management Change
        • 1.2.3.9 S.W.O.T Analysis
      • 1.2.4 UPMC
        • 1.2.4.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
        • 1.2.4.2 Business Overview
        • 1.2.4.3 Financials (Subject to data availability)
        • 1.2.4.4 R&D Investment (Subject to data availability)
        • 1.2.4.5 Product Types Specification
        • 1.2.4.6 Business Strategy
        • 1.2.4.7 Recent Developments
        • 1.2.4.8 Management Change
        • 1.2.4.9 S.W.O.T Analysis
      • 1.2.5 B BRAUN
        • 1.2.5.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
        • 1.2.5.2 Business Overview
        • 1.2.5.3 Financials (Subject to data availability)
        • 1.2.5.4 R&D Investment (Subject to data availability)
        • 1.2.5.5 Product Types Specification
        • 1.2.5.6 Business Strategy
        • 1.2.5.7 Recent Developments
        • 1.2.5.8 Management Change
        • 1.2.5.9 S.W.O.T Analysis
      • 1.2.6 Instrumentation Laboratory
        • 1.2.6.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
        • 1.2.6.2 Business Overview
        • 1.2.6.3 Financials (Subject to data availability)
        • 1.2.6.4 R&D Investment (Subject to data availability)
        • 1.2.6.5 Product Types Specification
        • 1.2.6.6 Business Strategy
        • 1.2.6.7 Recent Developments
        • 1.2.6.8 Management Change
        • 1.2.6.9 S.W.O.T Analysis

  • Chapter 2. Global Patient Blood Management Market Analysis

    • 2.1 Global Patient Blood Management Market Analysis
    • 2.2 Global Patient Blood Management Market Analysis by Region
    • 2.3 Global Patient Blood Management Market Analysis by Product Type
    • 2.4 Global Patient Blood Management Market Analysis by Component
    • 2.5 Global Patient Blood Management Market Analysis by End-User
    • 2.6 Global Patient Blood Management Market Analysis by Key Players

  • Chapter 3. North America Patient Blood Management Market Analysis

    • 3.1 North America Patient Blood Management Market Analysis
    • 3.2 North America Patient Blood Management Market Analysis by Country
    • 3.3 North America Patient Blood Management Market Analysis by Product Type
    • 3.4 North America Patient Blood Management Market Analysis by Component
    • 3.5 North America Patient Blood Management Market Analysis by End-User
    • 3.6 North America Patient Blood Management Market Analysis by Key Players

  • Chapter 4. Europe Patient Blood Management Market Analysis

    • 4.1 Europe Patient Blood Management Market Analysis
    • 4.2 Europe Patient Blood Management Market Analysis by Country
    • 4.3 Europe Patient Blood Management Market Analysis by Product Type
    • 4.4 Europe Patient Blood Management Market Analysis by Component
    • 4.5 Europe Patient Blood Management Market Analysis by End-User
    • 4.6 Europe Patient Blood Management Market Analysis by Key Players

  • Chapter 5. Asia Pacific Patient Blood Management Market Analysis

    • 5.1 Asia Pacific Patient Blood Management Market Analysis
    • 5.2 Asia Pacific Patient Blood Management Market Analysis by Country
    • 5.3 Asia Pacific Patient Blood Management Market Analysis by Product Type
    • 5.4 Asia Pacific Patient Blood Management Market Analysis by Component
    • 5.5 Asia Pacific Patient Blood Management Market Analysis by End-User
    • 5.6 Asia Pacific Patient Blood Management Market Analysis by Key Players

  • Chapter 6. South America Patient Blood Management Market Analysis

    • 6.1 South America Patient Blood Management Market Analysis
    • 6.2 South America Patient Blood Management Market Analysis by Country
    • 6.3 South America Patient Blood Management Market Analysis by Product Type
    • 6.4 South America Patient Blood Management Market Analysis by Component
    • 6.5 South America Patient Blood Management Market Analysis by End-User
    • 6.6 South America Patient Blood Management Market Analysis by Key Players

  • Chapter 7. Middle East Patient Blood Management Market Analysis

    • 7.1 Middle East Patient Blood Management Market Analysis
    • 7.2 Middle East Patient Blood Management Market Analysis by Country
    • 7.3 Middle East Patient Blood Management Market Analysis by Product Type
    • 7.4 Middle East Patient Blood Management Market Analysis by Component
    • 7.5 Middle East Patient Blood Management Market Analysis by End-User
    • 7.6 Middle East Patient Blood Management Market Analysis by Key Players

  • Chapter 8. Africa Patient Blood Management Market Analysis

    • 8.1 Africa Patient Blood Management Market Analysis
    • 8.2 Africa Patient Blood Management Market Analysis by Country
    • 8.3 Africa Patient Blood Management Market Analysis by Product Type
    • 8.4 Africa Patient Blood Management Market Analysis by Component
    • 8.5 Africa Patient Blood Management Market Analysis by End-User
    • 8.6 Africa Patient Blood Management Market Analysis by Key Players

  • Chapter 9. Product Type Analysis

    • 9.1 Accessories
      • 9.1.1 Global Accessories Market
      • 9.1.2 Global Accessories Market by Region
    • 9.2 Reagents and Kits
      • 9.2.1 Global Reagents and Kits Market
      • 9.2.2 Global Reagents and Kits Market by Region
    • 9.3 Software
      • 9.3.1 Global Software Market
      • 9.3.2 Global Software Market by Region
    • 9.4 Instruments
      • 9.4.1 Global Instruments Market
      • 9.4.2 Global Instruments Market by Region

  • Chapter 10. Component Analysis

    • 10.1 Plasma
      • 10.1.1 Global Plasma Market
      • 10.1.2 Global Plasma Market by Region
    • 10.2 Whole Blood
      • 10.2.1 Global Whole Blood Market
      • 10.2.2 Global Whole Blood Market by Region

  • Chapter 11. End-User Analysis

    • 11.1 Hospitals
      • 11.1.1 Global Hospitals Market
      • 11.1.2 Global Hospitals Market by Region
    • 11.2 Pathology Labs
      • 11.2.1 Global Pathology Labs Market
      • 11.2.2 Global Pathology Labs Market by Region
    • 11.3 Diagnostic Clinics
      • 11.3.1 Global Diagnostic Clinics Market
      • 11.3.2 Global Diagnostic Clinics Market by Region
    • 11.4 Blood Banks
      • 11.4.1 Global Blood Banks Market
      • 11.4.2 Global Blood Banks Market by Region

  • Chapter 12. Qualitative Analysis (Subject to Data Availability)

    • 12.1 Market Drivers
    • 12.2 Market Restraints
    • 12.3 Market Trends
    • 12.4 Market Opportunity
    • 12.5 Technological Road Map (Subject to Data Availability)
    • 12.6 Product Life Cycle (Subject to Data Availability)
    • 12.7 Customer and Buyer Behavior Analysis
      • 12.7.1 Digital Engagement, Customer Experience & Relationship Analysis
      • 12.7.2 Customer Buying Behavior & Purchase Decision Analysis
      • 12.7.3 Vendor Selection, Supplier Preferences & Future Demand Trends
      • 12.7.4 Pricing, Affordability & Value Perception Analysis
      • 12.7.5 Customer Segmentation & Demand Pattern Analysis
    • 12.8 PESTEL Analysis
      • 12.8.1 Political Factors
      • 12.8.2 Economic Factors
      • 12.8.3 Social Factors
      • 12.8.4 Technological Factors
      • 12.8.5 Legal Factors
      • 12.8.6 Environmental Factors
    • 12.9 Industrial Chain Analysis (Subject to Data Availability)
      • 12.9.1 Industry Chain Analysis
      • 12.9.2 Manufacturing Cost Analysis
      • 12.9.3 Supply Side Analysis
        • 12.9.3.1 Raw Material Analysis
        • 12.9.3.2 Raw Material Procurement Analysis
        • 12.9.3.3 Raw Material Price Trend Analysis
    • 12.10 Porter’s Five Forces Analysis
      • 12.10.1 Bargaining Power of Suppliers
      • 12.10.2 Bargaining Power of Buyers
      • 12.10.3 Threat of New Entrants
      • 12.10.4 Threat of Substitutes
      • 12.10.5 Degree of Competition
    • 12.11 Patent Analysis (Subject to Data Availability)
    • 12.12 ESG Analysis
    • 12.13 Geopolitical Outlook
      • 12.13.1 Global Power Realignment & Strategic Alliances
      • 12.13.2 Geopolitical Risk Landscape & Conflict Hotspots
      • 12.13.3 International Trade Relations & Market Access Environment
      • 12.13.4 Regulatory & Policy Shifts Impacting Cross-Border Operations
      • 12.13.5 Supply Chain Resilience, Localization & Resource Nationalism
      • 12.13.6 Technology Sovereignty & Digital Geopolitics
      • 12.13.7 Strategic Implications for Investment, Growth & Market Entry
    • 12.14 AI & Market Transformation
      • 12.14.1 Competitive Landscape Disruption & Strategic Shifts
      • 12.14.2 AI-Driven Transformation of Industry Value Chain
      • 12.14.3 Evolution of Business Models & Revenue Streams
      • 12.14.4 AI-Driven Product, Service & Innovation Transformation
      • 12.14.5 Customer Behavior, AI Adoption & Future Market Evolution

  • Chapter 13. TOP 10 Country Analysis

    • 13.1 Country 1
    • 13.2 Country 2
    • 13.3 Country 3
    • 13.4 Country 4
    • 13.5 Country 5
    • 13.6 Country 6
    • 13.7 Country 7
    • 13.8 Country 8
    • 13.9 Country 9
    • 13.10 Country 10

  • Chapter 14. Research Findings

    • 14.1 Key Takeaways
    • 14.2 Analyst Point of View
    • 14.3 Assumptions and Acronyms

  • Chapter 15. Research Methodology and Sources

    • 15.1 Primary Data Collection
      • 15.1.1 Steps for Primary Data Collection
        • 15.1.1.1 Identification of KOL
      • 15.1.2 Backward Integration
      • 15.1.3 Forward Integration
      • 15.1.4 How Primary Research Help Us
      • 15.1.5 Modes of Primary Research
    • 15.2 Secondary Research
      • 15.2.1 How Secondary Research Help Us
      • 15.2.2 Sources of Secondary Research
    • 15.3 Data Validation
      • 15.3.1 Data Triangulation
    • 15.4 Data Representation

Athenaeum AI Dashboard

Research Framework · 70:30 Primary:Secondary

Our Proprietary Methodology

Cognitive Market Research and Consulting "The Full Truth" methodology — a rigorous triangulation process that combines primary research, secondary validation, and expert calibration. Implemented by Supriya Yadav and team for the Patient Blood Management Market Analysis Market analysis.

01

Primary Intelligence Gathering

Direct interviews with 50+ industry stakeholders including manufacturers, distributors, end-users, and regulatory bodies across all six regions.

02

Secondary Data Triangulation

Cross-referencing against trade databases, customs records, financial filings, patent databases, and verified industry publications.

03

Expert Validation Protocol

Each data point undergoes validation by minimum two independent domain experts with 15+ years of industry experience.

04

Athenaeum AI Processing

Our proprietary AI platform aggregates, normalizes, and identifies patterns across 10,000+ data points to surface non-obvious insights.

05

Editorial & QA Review

Final review by senior analysts ensures accuracy, coherence, and actionability of all insights and recommendations.

Data Assurance Metrics
Data Points Validated 10,400+
Expert Interviews 54
Countries Covered 39+
Company Profiles 6+
Forecast Accuracy (Historical) 94.2%
Analytical Coverage
Market Sizing Revenue Forecast CAGR Analysis Competitor Benchmarking SWOT Porter's Analysis PESTEL Value Chain ESG Analysis Tariff Impact Patent Mapping Tech Trends

To maintain the integrity of our proprietary methodology and protect our elite expert network, specific source disclosures are reserved for full-access partners. Our research framework is anchored by a 70:30 primary-to-secondary ratio, ensuring your strategy is driven by real-time market intelligence rather than recycled, publicly available, or AI-generated data. Every deliverable includes an exhaustive source directory and grants direct analyst access.

Sources from the Pharma & Healthcare Industry

How We Serve You

The Three Pillars of End-to-End Market Research Services

We don't just hand over data. We partner with your team across three integrated service lines — each designed to give you decision-grade intelligence on the Patient Blood Management Market Analysis market.

Service 01

Market Survey

B2B B2C

Structured primary research across both B2B and B2C channels. We design and execute custom surveys targeting manufacturers, distributors, procurement heads, and end-consumers in the patient blood management market analysis ecosystem — validated by our global panel of 10,000+ industrial respondents.

What's Included
  • Buyer intent & sentiment analysis
  • Purchase cycle mapping
  • Price sensitivity research
  • Channel preference profiling
  • Competitive perception study
Most Requested
Service 02

Customized Market Data & Reports

Custom Ready Report

Choose from our ready-to-access 8th Edition report or commission a fully customized dataset tailored to your exact strategic questions. Cross-splits, custom geographies, proprietary segmentation — we build the intelligence asset your board actually needs.

What's Included
  • Ready syndicate report
  • Custom data scope & segmentation
  • Excel quantitative models
  • Board-ready PPT with key findings
  • Secure cloud portal access
Service 03

Strategic Consultation

With Survey With Report

Every survey and every report comes with dedicated analyst consultation. Our senior research team walks your leadership through findings, answers strategic questions in real-time, and helps translate data into your next board presentation or investment thesis.

What's Included
  • Dedicated analyst assigned to you
  • Live walkthrough of findings
  • Strategic Q&A sessions
  • Go-to-market recommendations
  • NDA-protected engagement

Customize This Report

Tell us the specific segments, regions, or companies you need — and we will tailor the deliverable to your requirements.